IBM Story Is Underappreciated, Goldman Sachs Says Stock Can Re-Rate Higher

Benzinga
02-06

Goldman Sachs analyst James Schneider expressed views on International Business Machines Corporation‘s (NYSE:IBM) Investor Day, which took place on February 4.

The analyst maintained a Buy rating and a $275 price forecast, considering the company remains underappreciated in the TMT sector and offers discovery value, especially for long-only investors.

The analyst notes that IBM projects over 5% total revenue growth from 2025 to 2027, including M&A, with pre-tax margin and FCF growth outpacing revenue growth.

The analyst notes the stock should continue to rise, as IBM has outlined a credible strategy to sustain accelerated long-term Software revenue growth of around 10%, surpassing their previous expectation of high-single digits for 2025-2027.

Moreover, Schneider notes that IBM raised its medium-term Software revenue growth target to 10%, up from mid-single digits, with Red Hat seeing mid-teens growth.

The analyst sees a potential upside in IBM’s Software growth and margins, fueled by increasing demand for containerization, OpenShift, Ansible, and RHEL.

Additionally, IBM’s early leadership in GenAI, with ~$1 billion in Software GenAI bookings to date, presents further growth opportunities, adds the analyst.

Also, the analyst notes that IBM expects Consulting business to outperform the market through share gains, and Infrastructure business is forecasted to grow 1%-3%, on mainframe and storage growth.

Overall, the analyst notes the company is on track to achieve long-term growth driven by stronger software growth and market share gains in the consulting business.

Last month, IBM reported fourth-quarter earnings of $3.92 per share, which beat the analyst consensus estimate of $3.75. Quarterly revenue came in at $17.55 billion, which beat the analyst consensus estimate of $17.54 billion.

Investors can gain exposure to the stock via First Trust NASDAQ Technology Dividend Index Fund (NASDAQ:TDIV) and FT Vest Technology Dividend Target Income ETF (BATS:TDVI).

Price Action: IBM shares are down 0.80% at $262.33 at the last check Wednesday.

Read Next:

  • Workers Long for The Day Pensions Make A Comeback — 83% Say Everyone Deserves A Pension, Not Just Public Employees

Photo via Shutterstock.

Latest Ratings for IBM

Date Firm Action From To
Jan 2022 BMO Capital Maintains Market Perform
Jan 2022 UBS Downgrades Neutral Sell
Jan 2022 Goldman Sachs Initiates Coverage On Neutral

View More Analyst Ratings for IBM

View the Latest Analyst Ratings

Up Next: Transform your trading with Benzinga Edge's one-of-a-kind market trade ideas and tools. Click now to access unique insights that can set you ahead in today's competitive market.

Get the latest stock analysis from Benzinga?

  • IBM (IBM): Free Stock Analysis Report

This article IBM Story Is Underappreciated, Goldman Sachs Says Stock Can Re-Rate Higher originally appeared on Benzinga.com

© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10